Clinical trials
Terminated Arrhythmias, Cardiac trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2017 | 4 |
| 2018 | 3 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 50 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emory University | 3 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 3 |
| Abbott Medical Devices | 2 |
| Biosense Webster, Inc. | 2 |
| EPD Solutions, A Philips Company | 2 |
| Medtronic Cardiac Rhythm and Heart Failure | 2 |
| Universitair Ziekenhuis Brussel | 2 |
| Biotronik SE & Co. KG | 1 |
| Boston Scientific Corporation | 1 |
| CHAD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arrhythmias, Cardiac | 50 |
| Atrial Fibrillation | 18 |
| Heart Diseases | 7 |
| Heart Failure | 7 |
| Cardiovascular Diseases | 4 |
| Tachycardia | 4 |
| Tachycardia, Ventricular | 4 |
| Atrial Flutter | 3 |
| Myocardial Infarction | 3 |
| Anxiety Disorders | 2 |
Trials
Showing 51 to 50 of 50. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.